MINERALYS THERAPEUTICS INC (MLYS:NASDAQ)
$26.87 0.25 (0.9391%)
Analysed MINERALYS THERAPEUTICS INC (MLYS:NASDAQ) News Sources
Does Mineralys Therapeutics’ (MLYS) FDA Progress and Legal Hire Reshape Its Cardiorenal Commercialization Strategy?
07-04-2026
yahoo.com
Mineralys Therapeutics' CEO Sold Shares Worth $1.97 Million. Should Investors Avoid the Stock?
07-04-2026
fool.com
Avalyn Appoints Jon Congleton, Seasoned Biopharmaceutical Executive, to its Board of Directors
06-04-2026
yahoo.com
Mineralys Therapeutics (MLYS) Garnering Attention With Lorundrostat Progress
01-04-2026
yahoo.com
Immunic appoints biopharmaceutical executive Jon Congleton to board
31-03-2026
proactiveinvestors.com
Mineralys Therapeutics Appoints Jeffrey A. Munsie as Chief Legal Officer
24-03-2026
yahoo.com
Is It Time To Reassess Mineralys Therapeutics (MLYS) After The Recent Share Price Pullback?
20-03-2026
yahoo.com
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
16-03-2026
yahoo.com
Mineralys Therapeutics (MLYS) Makes Progress With FDA For Hypertension
13-03-2026
yahoo.com
Cancer Drug Maker With $172 Million Revenue and Multiple Approved Therapies Draws $6.5 Million Investment
13-03-2026
fool.com
What is the current price of MINERALYS THERAPEUTICS INC (MLYS:NASDAQ)?
The current price of MINERALYS THERAPEUTICS INC (MLYS:NASDAQ) is $26.87.
MINERALYS THERAPEUTICS INC (MLYS:NASDAQ) absolute price change since previous trading day?
The absolute price change of MINERALYS THERAPEUTICS INC (MLYS:NASDAQ) since the previous trading day is $0.25.
MINERALYS THERAPEUTICS INC (MLYS:NASDAQ) percentage price change since previous trading day?
The percentage price change of MINERALYS THERAPEUTICS INC (MLYS:NASDAQ) since the previous trading day is 0.9391%.
What is the most recent average sentiment score for MINERALYS THERAPEUTICS INC (MLYS:NASDAQ)?
The most recent average sentiment score for MINERALYS THERAPEUTICS INC (MLYS:NASDAQ) is 88 out of 100.
What is the most recent average sentiment for MINERALYS THERAPEUTICS INC (MLYS:NASDAQ)?
The most recent sentiment for MINERALYS THERAPEUTICS INC (MLYS:NASDAQ) is .
SEC-8K** Filing Available For MINERALYS THERAPEUTICS INC (MLYS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.